Background: Over a decade of years, from 1999–2008, guidelines for treatment of patients with
myocardial infarction (MI) have been regularly updated and new definitions for acute
MI have been established. Aim of the present study was to investigate the changes
in treatment and hospital mortality over this 10-year period in acute MI-patients
under the influence of the implementation of guideline-based therapy and the redefinition
of acute myocardial infarction in Berlin, Germany. Methods: In the BMIR, data of patients with acute myocardial infarction (AMI) have been collected
prospectively since 1999. We analyzed data from 1.1.1999–1.4.2008 of 11 hospitals
continuously participating in the BMIR. We consecutively included 9830 MI patients.
Demographic data, data on reperfusion therapy and discharge medication, and on hospital
mortality were analyzed. Results:
|
*p Chi Square Trend Test
|
|
|
1999/2000
|
N=1645 2001/2002
|
n=1719 2003/2004
|
n=2250 2005/2006
|
N=2327 2007/1.4.2008
|
n=1889 p*
|
|
female gender
|
33.9%
|
33.2%
|
36.0%
|
35.4%
|
32.3%
|
0.633
|
|
Age >75 years
|
30.6%
|
27.2%
|
30.4%
|
34.5%
|
27.9%
|
0.413
|
|
Time from symptom onset to hospital arrival ≤2h
|
48.7%
|
47.8%
|
42.6%
|
41.7%
|
42.2%
|
<0.001
|
|
STEMI (vs. NSTEMI)
|
76.4%
|
76.1%
|
62.6%
|
54.4%
|
49.5%
|
<0.001
|
|
Physician escorted rescue system
|
44.1%
|
42.0%
|
44.3%
|
50.1%
|
49.6%
|
<0.001
|
|
Primary PCI
|
18.4%
|
40.4%
|
62.3%
|
76.8%
|
79.9%
|
<0.001
|
|
Thrombolysis
|
40.6%
|
29.8%
|
9.8%
|
3.4%
|
1.1%
|
<0.001
|
|
ASA and/or clopidogrel on discharge
|
91.1%
|
94.5%
|
97.1%
|
96.7%
|
97.7%
|
<0.001
|
|
Beta-blockers on discharge
|
70.3%
|
76.8%
|
76.8%
|
84.5%
|
87.8%
|
<0.001
|
|
ACE-inhibitors and/or ARBs on discharge
|
76.5%
|
83.9%
|
89.5%
|
89.3%
|
92.4%
|
<0.001
|
|
CSE-inhibitors on discharge
|
39.8%
|
57.5%
|
69.1%
|
76.8%
|
85.3%
|
<0.001
|
|
hospital-mortality
|
12.2%
|
11.8%
|
8.5%
|
7.8%
|
6.2%
|
<0.001
|
Conclusions: Over the 10 year period the total number and the percentage of NSTEMI-patients increased
probably due to redefinition of acute myocardial infarction. Adherence to guidelines
increased and hospital mortality was lowered, but time between symptom onset and hospital
arrival increased.